WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010138488) HEPATITIS C VIRUS INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/138488    International Application No.:    PCT/US2010/036033
Publication Date: 02.12.2010 International Filing Date: 25.05.2010
IPC:
C07D 413/10 (2006.01), C07D 413/14 (2006.01), C07D 403/10 (2006.01), C07D 403/14 (2006.01), A61K 31/4178 (2006.01), A61P 31/14 (2006.01)
Applicants: BRISTOL-MYERS SQUIBB COMPANY [US/US]; P.O. Box 4000 Route 206 and ProvinceLine Road Princeton, New Jersey 08543-4000 (US) (For All Designated States Except US).
LAVOIE, Rico [CA/CA]; (CA) (For US Only).
JAMES, Clint A. [CA/CA]; (CA) (For US Only).
RUEDIGER, Edward H. [CA/CA]; (CA) (For US Only)
Inventors: LAVOIE, Rico; (CA).
JAMES, Clint A.; (CA).
RUEDIGER, Edward H.; (CA)
Agent: MINGO, Pamela A.; Bristol-Myers Squibb Company P.O. Box 4000 Princeton, New Jersey 08543-4000 (US)
Priority Data:
61/182,162 29.05.2009 US
Title (EN) HEPATITIS C VIRUS INHIBITORS
(FR) INHIBITEURS DU VIRUS DE L'HÉPATITE C
Abstract: front page image
(EN)This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
(FR)L'invention porte sur de nouveaux composés de formule (I) tels que définis dans la divulgation et sur des compositions comprenant de tels nouveaux composés. Ces composés sont des agents antiviraux utiles, notamment dans l'inhibition de la fonction de la protéine NS5A codée par le virus de l'hépatite C (VHC). Ainsi, l'invention porte sur un procédé de traitement de maladies ou d'états liés au VHC par l'utilisation de ces nouveaux composés ou d'une composition comprenant de tels nouveaux composés.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)